A healthcare research firm is looking to identify adolescent hTTP patients in both the US and UK living with hereditary thrombotic thrombocytopenic purpura (hTTP). The main study has been completed. This research may help improve how the patient’s experience is accounted for in clinical trials for new treatments, and may also lead to interventions designed to better support patients and their families going through the treatment experience.
For more information and for participation instructions click here.
NB: Mention of any treatment products associated with this study are provided for information only and their inclusion is not an endorsement of a particular product or company by Answering TTP Foundation.